Tag

biopharmaceuticals

BMWS20 – Opening Chairs’ Remarks and Keynote: Reinventing a Biopharma Company for the 21st Century
LIFE SCIENCES, LIFE SCIENCES, VIDEO

BMWS20 – Opening Chairs’ Remarks and Keynote: Reinventing a Biopharma Company for the 21st Century

Bristol Myers Squibb is a company that has undergone an extensive transformation and as a result, has reinvented itself Once a company consisting of multiple and vastly different business units, it is now the largest diversified specialty global biopharma company Its mission and focus is to utilize innovation to advance the treatment of serious disease and significant unmet medical need This organizational evolution required substantial change for the product development and manufacturing arms of the company Technology, systems, processes, people and culture all needed to be re-evaluated through a “new lens” The presentation will cover this journey including approach, successes,…

Continue reading
Panel: Looking at the Big Picture: Where is Our Industry Going, and How Should We Get There?
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Panel: Looking at the Big Picture: Where is Our Industry Going, and How Should We Get There?

Debating the merits of nimble and flexible facilities versus manufacturing battleships Preparing your pilot plants and manufacturing facilities to move forward with Phase II-III approvals Forecasting requirements for optimizing manufacturing equipment, facilities and partners to increase speed to market Achieving business goals to better manage times of product and economic uncertainty Putting theory into practice: Implementing key metrics to improve manufacturing flexibility — Moderators: Pat Yang Chairman at Acepodia & Founding Board Director at Sana Biotechnology Dr. Patrick Y. Yang has over 35 years leadership experience in technology, manufacturing, supply chain, and operational management functions in General Electric, Merck, Genentech,…

Continue reading
Disrupting Quality Standards (or Beliefs) Through Digitalization
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Disrupting Quality Standards (or Beliefs) Through Digitalization

 The current state of digital transformation in life science How to disrupt the quality standards: Digital transformation roadmap and the situation ongoing at SBL Digital transformation’s Value proposition: Improve quality, productivity, and for unparalleled client experience Samsung Biologics’ P4 plan and vision: We’re building the future Sam MacHour SVP & Chief Quality Officer Samsung Biologics Prior to joining Samsung Biologics in 2019, Sam spent more than 32 years supporting large MedTech, Bioscience and Biopharmaceutical companies achieve business operational excellence and gain leadership in the areas of Research & Development, Quality, Compliance, Regulatory, Operations and product commercialization. Sam’s experience covers…

Continue reading
Panel: Staying Ahead of the Curve in the Increasingly Complex Regulatory World of Cell and Gene Therapy
LIFE SCIENCES

Panel: Staying Ahead of the Curve in the Increasingly Complex Regulatory World of Cell and Gene Therapy

Discussing the growing regulatory complexity in the world of pharmaceutical manufacturing. How are new guidelines and regulators’ expectations during inspections changing? Taking a process-based approach to impact assessment, and customizing a setup that identifies and acts on signals proactively Bringing a structured approach to your advocacy within your network of industry and trade organization connections Embracing the idea that keeping things simple even in a complex environment generates the best outcomes — Pat Yang Former EVP at Juno Therapeutics, Roche and Genentech Dr. Patrick Y. Yang has over 35 years leadership experience in technology, manufacturing, supply chain, and operational management…

Continue reading
Digital Transformation and the Smart Factory – A Conversation with Laks Pernenkil of Deloitte Consulting LLP
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Digital Transformation and the Smart Factory – A Conversation with Laks Pernenkil of Deloitte Consulting LLP

 At the 2019 edition of the Biomanufacturing World Summit series earlier this month in San Diego we spoke with Laks Pernenkil, Principal | Life Sciences Operations with Deloitte Consulting LLP. Laks shared his insights into digital transformation in general, and specifically how the ‘Smart Factory’ will change the way biopharmaceutical companies operate. — Deloitte Life Sciences Innovation starts with insight and seeing challenges in a new way. Amid unprecedented uncertainty and change, life sciences stakeholders are looking for new ways to transform their organizations using digital innovation and technologies. Deloitte’s team of thinkers and doers can help you imagine,…

Continue reading
Compliance, Quality, and Risk – A Conversation with Jack Garvey of Compliance Architects
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Compliance, Quality, and Risk – A Conversation with Jack Garvey of Compliance Architects

At the 2019 edition of the Biomanufacturing World Summit series earlier this month in San Diego we spoke with Jack Garvey, Compliance Architects’ co-founder and CEO. Jack has chaired the Quality stream of content for several Biomanufacturing World Summits, and he has deep insights to offer biopharmaceutical manufacturers looking to communicate with regulators and build their organizations to better address the issues of Compliance, Quality, and Risk. — Jack Garvey CEO Compliance Architects Jack Garvey is the Founder and Chief Executive Officer of Compliance Architects®, a leading consulting and advisory firm specializing in innovative quality and compliance solutions for FDA-regulated…

Continue reading
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Keynote: The Successful History of Biologics Manufacturing Provides Foresights and Strategies for New Bio Modalities

Establishment of broad communities of practitioners in both manufacturing and process development accelerated maturation of both disciplines Convergence of these process and manufacturing technologies was driven by excellence and capacity in selected CMOs Manufacturing portability has provided remarkable stories of win-win capacity-exchange between proprietary companies Process convergence has resulted in remarkable progress in process yields and cost improvement Intro to Vir Bio: Capacity and cost improvements in bio-manufacturing facilitate global access to medicines for Infectious Disease — Michael Kamarck Chief Technology Officer Vir Biotechnology Michael Kamarck is Chief Technology Officer at Vir. Previously, he was senior vice president of Global…

Continue reading
Improving Product Quality During Technical Transfers
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Improving Product Quality During Technical Transfers

The definition of Technology Transfer and its many applications Planning for tech transfer the “right way,” using “Calculated Risk Reduction” and other tools to ensure all bases are covered Common pitfalls and best practices – what to do, and what not to do Ways to ensure optimal planning and execution using actionable tools — Eric Good Director, Compliance ProPharma Group Dr. Eric Good is an energetic leader with extensive U.S. and international manufacturing, project management, Consent Decree and quality systems experience with Fortune 500 Companies. Dr. Good has 29 years of award winning high-performance. He is an active leader in…

Continue reading
Scaling Gene Therapy Manufacturing: What is Our Goal?
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Scaling Gene Therapy Manufacturing: What is Our Goal?

Highlighting the scale-up opportunity for dramatic patient benefit through the lens of a patient Outlining the inextricable link between manufacturing and the patient experience for autologous cell therapies Considering the different scaling goals: commercial viability, reliability, patient access, etc. — Derek Adams Chief Technology and Manufacturing Officer bluebird bio Derek Adams joined bluebird bio in March 2017 as Chief Technology and Manufacturing Officer leading all pharmaceutical sciences that includes process and analytical development, manufacturing, technical operations, and supply chain. Prior to joining bluebird, Derek was the Senior Vice President of CMC at Evelo Biosciences. At Evelo, Derek established the initial…

Continue reading
The Centenarian and the Start Up: How Merck is Realizing its Biomanufacturing Revolution
LIFE SCIENCES, LIFE SCIENCES, VIDEO

The Centenarian and the Start Up: How Merck is Realizing its Biomanufacturing Revolution

Discuss how today’s pipeline and technologies are reshaping our biomanufacturing Review case studies and strategies for rapid manufacturing scale up for leading products Focus on the criticality of investing in people and robust strategies to support the workforce and culture Show opportunities that allow for successful navigation in the future of manufacturing, including leveraging legacy and culture as drivers of change — Karin Shanahan SVP, Global Biologics & Sterile Operations Merck Karin is SVP, Global Biologics and Sterile Operations at Merck Pharmaceutical where she holds operational responsibility for manufacturing Keytruda and Gardasil in addition to other in-line and pipeline products….

Continue reading
Technology Roadmap for the Biopharmaceutical Industry
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Technology Roadmap for the Biopharmaceutical Industry

Proving that the most valuable data in manufacturing is from production itself Choosing the right goals and outcomes to make a difference Connecting disparate IT systems together into a unified whole Building a scalable approach for the enterprise, step-by-step: Start small to go big Illustrating successful projects with concrete examples — Jun Huang Director/Team Leader, Process Monitoring, Automation & Control Pfizer Dr. Jun Huang is Director/Team Leader, with the Process Monitoring, Automation and Control group, part of Pfizer Global Technology & Engineering, based in NJ. He leads a team responsible for the development and implementation of Advanced Analytics, AI/ML, Advanced…

Continue reading
Leveraging Predictive Technologies to Ensure Supply Chain Health – Case Study
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Leveraging Predictive Technologies to Ensure Supply Chain Health – Case Study

Deployed artificial and business intelligence to detect events that may create product availability issues, demand and supply related Implemented an automated management alarm and escalation system, emails and text messages, to accelerate response to supply-impacting events Implemented demand-driven scheduling system to connect production mix with actual demand Connected and integrated data across multiple platforms, e.g. PLCs, ERPs, QMS, LIMS, etc. — Jaime Velez Co-Founder Operations & Quality Systems Improvement Experts (OQSIE) For the last 15 years Jaime has supported more than one hundred consulting engagements with Life Science companies delivering significant productivity improvements in supply chain and quality systems. He…

Continue reading
Global Talent Trends in Biomanufacturing 2019
LIFE SCIENCES, LIFE SCIENCES, VIDEO

Global Talent Trends in Biomanufacturing 2019

An update on talent trends: what does it (seem to) take to make it to the top? Should I lead, over the next 10 years, the way I lead over the past 10 years? Culture: what is it (really) and how can we transform it as leaders? — Pascal Bécotte Co-Leader, Corporate Officers Sector (Global Functions) & Global Leader, Operations & Supply Chain Practice Russell Reynolds Associates Dr. Pascal Bécotte co-leads the firm’s global Corporate Officers Sector and leads the global Operations & Supply Chain Officers Practice. Pascal is also a key member of the Healthcare and Industrial Sectors, where…

Continue reading
Why Executive Platforms Decided to Launch Pharma Manufacturing World as Our Seventh Summit Series
LIFE SCIENCES, White Paper, WHITEPAPER

Why Executive Platforms Decided to Launch Pharma Manufacturing World as Our Seventh Summit Series

An Open Letter by Geoff Micks Head of Content & Research Executive Platforms   Those of you who follow us on Twitter or LinkedIn may have already seen the ‘Save the Date’ announcement for Executive Platforms’ newest summit series, Pharma Manufacturing World Summit. The first edition of which will run June 22nd and 23rd, 2020, at the Boston Marriott Copley Place. We are very excited about it, as you can imagine. Or maybe you cannot? It occurs to me that with each of the last six series Executive Platforms has launched, we never made a public announcement explaining our thinking…

Continue reading
Evolving External Collaboration Models
LIFE SCIENCES, VIDEO

Evolving External Collaboration Models

Reviewing how our industry’s business partnerships have changed over time. How will this trend continue into the future? Dividing the work and sharing the burden: How should biopharmaceutical companies align their objectives of cost management, risk management, productivity, and growth? Maturing business relationships over time through common culture through two-way communication, collaboration, and cooperation Walking through examples of external collaboration: What works, what does not, and why? — Joanne Beck EVP, Global Pharmaceutical Development & Operations Celgene Corporation Dr. Joanne Beck is EVP Global Pharmaceutical Development and Operations at Celgene where she oversees the company’s Pharmaceutical Development, Global Manufacturing Operations,…

Continue reading